- Report
- October 2023
- 145 Pages
Global
From €2874EUR$3,150USD£2,471GBP
- Report
- August 2022
- 67 Pages
Global
- Report
- January 2025
- 132 Pages
Global
From €867EUR$950USD£745GBP
- Report
- November 2021
- 1184 Pages
Global
From €5474EUR$6,000USD£4,707GBP
- Book
- August 2014
- 240 Pages
- Book
- September 2024
- 304 Pages
- Book
- February 2020
- 448 Pages
Cell reprogramming is a biotechnology process that involves the conversion of a cell from one type to another. It is used to create induced pluripotent stem cells (iPSCs) from adult cells, which can then be used to study diseases, develop new treatments, and create personalized medicine. Cell reprogramming is also used to create cell models of diseases, which can be used to study the underlying mechanisms of the disease and develop new therapies. Additionally, cell reprogramming can be used to create cell-based therapies, such as gene therapy, which can be used to treat genetic diseases.
Cell reprogramming is a rapidly growing field, with many companies investing in the technology. Some of the companies in the market include Ginkgo Bioworks, Cellular Dynamics International, Fate Therapeutics, and Pluristem Therapeutics. Show Less Read more